Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,509 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
End-of-life care of oncology inpatients: Are we getting it right?
Batten M, Nguyen B, Burke B, Harryanto H, Mitchell I, Davis A. Batten M, et al. Among authors: davis a. Asia Pac J Clin Oncol. 2018 Oct;14(5):e528-e534. doi: 10.1111/ajco.13001. Epub 2018 Jun 13. Asia Pac J Clin Oncol. 2018. PMID: 29900665
Carboplatin and hypomagnesemia: Is it really a problem?
Gaughran G, Qayyum K, Smyth L, Davis A. Gaughran G, et al. Among authors: davis a. Asia Pac J Clin Oncol. 2021 Dec;17(6):478-485. doi: 10.1111/ajco.13481. Epub 2020 Oct 13. Asia Pac J Clin Oncol. 2021. PMID: 33052033
Exercise during CHemotherapy for Ovarian cancer (ECHO) trial: design and implementation of a randomised controlled trial.
Hayes S, Obermair A, Mileshkin L, Davis A, Gordon LG, Eakin E, Janda M, Beesley VL, Barnes EH, Spence RR, Sandler C, Jones T, Vagenas D, Webb P, Andrews J, Brand A, Lee YC, Friedlander M, Pumpa K, O'Neille H, Williams M; ECHO Collaborative; Stockler M; ECHO trial. Hayes S, et al. Among authors: davis a. BMJ Open. 2023 Apr 13;13(4):e067925. doi: 10.1136/bmjopen-2022-067925. BMJ Open. 2023. PMID: 37055210 Free PMC article. Clinical Trial.
Tumor size and survival in multicentric and multifocal breast cancer.
Rezo A, Dahlstrom J, Shadbolt B, Rodins K, Zhang Y, Davis AJ; ACT & SENSW BCTG. Rezo A, et al. Among authors: davis aj. Breast. 2011 Jun;20(3):259-63. doi: 10.1016/j.breast.2011.01.005. Epub 2011 Feb 15. Breast. 2011. PMID: 21324695 Free article.
PARAGON: A Phase II study of anastrozole in patients with estrogen receptor-positive recurrent/metastatic low-grade ovarian cancers and serous borderline ovarian tumors.
Tang M, O'Connell RL, Amant F, Beale P, McNally O, Sjoquist KM, Grant P, Davis A, Sykes P, Mileshkin L, Moujaber T, Kennedy CJ, deFazio A, Tan K, Antill Y, Goh J, Bonaventura T, Scurry J, Friedlander M. Tang M, et al. Among authors: davis a. Gynecol Oncol. 2019 Sep;154(3):531-538. doi: 10.1016/j.ygyno.2019.06.011. Epub 2019 Jun 18. Gynecol Oncol. 2019. PMID: 31227223 Clinical Trial.
Symptom burden and quality of life with chemotherapy for recurrent ovarian cancer: the Gynecologic Cancer InterGroup-Symptom Benefit Study.
Lee YC, King MT, O'Connell RL, Lanceley A, Joly F, Hilpert F, Davis A, Roncolato FT, Okamoto A, Bryce J, Donnellan P, Oza AM, Avall-Lundqvist E, Berek JS, Ledermann JA, Berton D, Sehouli J, Feeney A, Kaminsky MC, Diamante K, Stockler MR, Friedlander ML; GCIG Symptom Benefit Group. Lee YC, et al. Among authors: davis a. Int J Gynecol Cancer. 2022 Jun 6;32(6):761-768. doi: 10.1136/ijgc-2021-003142. Int J Gynecol Cancer. 2022. PMID: 35086926 Free PMC article.
6,509 results